Skip to main content
All lobbying filings

RK STRATEGIES, INC.

Lobbying for ADIAL PHARMACEUTICALS, INC. · Pharmaceutical company

 Filing 2nd Quarter - Termination
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $10,000.00 income · posted Jul 18, 2026

Official filing document

 Bills named in this filing 2
  • HR 7091
    Expanding Veterans’ Access to Emerging Treatments Act
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
 Lobbying activity 2
Health Issues

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027

Defense

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem